10 Stocks Fall Behind Amid Market Optimism

6. 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP)

60 Degrees Pharmaceuticals saw its share prices drop by 12.89 percent on Wednesday to end at $2.5 apiece after earning a negative rating from Weiss Ratings.

In its recent report, Weiss gave the company a Sell rating on the stock. The outlook followed HC Wainwright’s report last March 28 where it gave SXTP a Neutral rating.

In recent news, SXTP said it signed a patent license agreement with Yale School of Medicine and Yale School of Public Health to advance the development and commercialization of tafenoquine to treat and prevent babesiosis.

Caused by Babesia, a microscopic parasite, the infectious disease spreads through black-legged ticks carried by deer. According to the company, it is particularly severe in the elderly and those who are immunosuppressed.

According to SXTP, a randomized clinical trial is underway to evaluate tafenoquine’s safety and efficacy in treating humans with severe babesiosis.